CiteScore measures average citations received per document published in the serial.
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Overview | |
Publisher | BMC |
Language | English |
Frequency | Continuous publication |
Article Processing Charges | EUR 2590 | USD 2990 | GBP 2090 |
Publication Time | 12 |
Editorial Review Process | Anonymous peer review |
General Details | |
Language | English |
Society/Institute/Sponsor | BrightFocus Foundation |
Frequency | Continuous publication |
Publication Start Year | 2006 |
Publisher URL | Visit website |
Website URL | Visit website |
Publication Details | |
Plagiarism | Visit website |
Waiver Policy | Visit website |
Publication Time | 12 |
Article Processing Charges | EUR 2590 | USD 2990 | GBP 2090 |
Editorial Review Detail | |
Editorial Team | Visit website |
Review Process | Anonymous peer review |
Review Url | Visit website |
Information for authors | |
Author instructions | Visit website |
Copyright Details | Visit website |
Deposit Policy | Sherpa/Romeo |
License type | CC BY, CC0 |
OA statement | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperMolecular Neurodegeneration has been in operation since 2006 till date.
Molecular Neurodegeneration published with a Continuous publication frequency.
In 2023, Molecular Neurodegeneration published 100 articles.
For Molecular Neurodegeneration,eISSN is 1750-1326 and pISSN is1750-1326.
Citescore for Molecular Neurodegeneration is 21.1.
SNIP score for Molecular Neurodegeneration is 2.7.
BMC is the publisher of Molecular Neurodegeneration.